MIRADOR
Live / Applied — Second extension granted (statement of use) (as of 25 Nov 2025)
What this means for you
Not registered yet, but its 09 Nov 2023 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98262767
- Mark type
- Stylized text
- Filed
- 09 Nov 2023
- Published for opposition
- 01 Oct 2024
- Attorney of record
- Brent D. Sokol
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the diagnosis, prevention, or treatment of inflammation and immunology disorders or diseases, autoimmune diseases, cancer, and other diseases of the immune systems, digestive systems, skin, joint, lung, liver, kidney, bile duct, nervous systems, or gastrointestinal systems; Diagnostic preparations for medical purposes; Diagnostic kits consisting primarily of monoclonal antibodies for use in disease testing; Chemical, biological and biochemical reagents for medical or veterinary purposes; Diagnostic test kits comprised of medical diagnostic reagents and assays that test for the presence of antigens, pathogens, biomarkers for diseases, or biomarkers for predicting patients' response to therapeutic agents
Owner
- Mirador Therapeutics, Inc., San Diego, CA, US
- Mirador Therapeutics, Inc., San Diego, CA, US
Prosecution history
- 31 Jul 2026 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 29 Jul 2026 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 26 May 2026 — TEAS STATEMENT OF USE RECEIVED
- 26 May 2026 — SOU TEAS EXTENSION RECEIVED
- 26 May 2026 — TEAS REQUEST TO DIVIDE RECEIVED
- 02 Apr 2026 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 02 Apr 2026 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 02 Apr 2026 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 26 Nov 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 25 Nov 2025 — SOU EXTENSION 2 GRANTED
- 25 Nov 2025 — SOU EXTENSION 2 FILED
- 25 Nov 2025 — SOU TEAS EXTENSION RECEIVED
- 30 Apr 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 30 Apr 2025 — SOU EXTENSION 1 GRANTED
- 29 Apr 2025 — SOU EXTENSION 1 FILED